How Insilico Medicine uses AI to accelerate drug development
Alex Zhavoronkov, co-founder and CEO of Insilico Medicine Alex Zhavoronkov Within the longevity research community, Alex Zhavoronkov is well known for his relentless focus. He works seven days a week and does not take vacations. The hard work pays off: In February, Insilico Medicine, the AI drug development company he founded, announced the first phase …
How Insilico Medicine uses AI to accelerate drug development Read More »